Innovent Biologics, Inc. - SIC # 8748 - BUSINESS CONSULTING SERVICES, NOT ELSEWHERE CLASSIFIED

Ticker Exchange SIC # Website Latest Ticker
IVBIY Over the counter 8748 www.innoventbio.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Innovent Biologics, Inc.

Top China Biopharma Stocks to Watch, According to Bernstein - Sep 30th, 2026 12:18 am
Innovent Biologics (SEHK:1801) Stock Still Looks Below Fair Value As Shares Rose 153% - Sep 29th, 2026 5:10 pm
2026 IMS Oral Presentation: Innovent Announces Updated Phase 1 Clinical Data of Trispecific Antibody IBI3003 (GPRC5D/BCMA/CD3) in Patients with Relapsed or Refractory Multiple Myeloma - Sep 29th, 2026 1:45 am
Jaypirca® (pirtobrutinib) Approved in China for a New Indication in Chronic Lymphocytic Leukemia (CLL) /Small Lymphocytic Lymphoma (SLL) Across All Lines of Therapy - Sep 28th, 2026 4:30 am
Innovent Announces Expansion of Global Phase 3 MarsLight-11 Study of IBI363/TAK-928 (Alpha-biased IL-2/PD-1 Bispecific Fusion Protein) in Immunotherapy-Resistant NSCLC to Include Patients with Non-Squamous NSCLC - Sep 27th, 2026 6:00 pm
Lilly’s latest China drug deal; Immunovant’s setback in lupus - Sep 24th, 2026 8:14 am
Innovent to Present New Clinical Data of Next-gen IO and ADC Pipeline at the 2026 ESMO Annual Meeting - Sep 23rd, 2026 2:48 am
Altruist Biologics' Suzhou Site Receives EMA GMP Certification, Enabling Product Commercialization for the European Market - Sep 22nd, 2026 8:00 am
Altruist Biologics Congratulates Partner LongBio Pharma on the BLA Acceptance of LP-003 by the China NMPA - Sep 14th, 2026 7:00 am
OPKO Health (OPK) Cashes In A Future Royalty Stream Early - Sep 13th, 2026 9:07 pm
2026 Complement Inhibitors Market Analysis Report (2nd Edition) Featuring Amgen, CSL Behring, Innovent Biologics, Novartis, Regeneron, Roche, Sanofi, Takeda, UCB - Sep 2nd, 2026 5:17 am
Which China stocks stand to win From the AI boom? UBS names its picks - Aug 27th, 2026 7:25 am
Market Chatter: Novo Nordisk Reports China Regulators Accept Weight-Loss Drug Application - Aug 27th, 2026 2:09 am
Innovent Announces 2026 Interim Results and Business Updates - Aug 25th, 2026 4:15 am
Spero Therapeutics Announces Second Quarter 2026 Operating Results and Provides Business Update - Aug 12th, 2026 2:01 pm
Innovent and Daiichi Sankyo sign deal for Vanflyta in China - Aug 10th, 2026 4:44 am
Innovent Biologics and Daiichi Sankyo Enter Exclusive Agreement for VANFLYTA® Commercialization in China - Aug 9th, 2026 6:00 pm